Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$5.82M Sell
23,153
-2,203
-9% -$541K 1.52% 9
2022
Q4
$6.94M Buy
25,356
+451
+2% +$121K 1.92% 8
2022
Q3
$6.18M Sell
24,905
-3,852
-13% -$934K 1.74% 9
2022
Q2
$7.12M Buy
28,757
+4,234
+17% +$1.04M 1.89% 7
2022
Q1
$6.15M Buy
24,523
+11,014
+82% +$2.53M 1.47% 15
2021
Q4
$3.14M Buy
13,509
+4,155
+44% +$877K 0.68% 47
2021
Q3
$1.96M Sell
9,354
-1,489
-14% -$343K 0.44% 61
2021
Q2
$2.65M Sell
10,843
-2,280
-17% -$561K 0.59% 46
2021
Q1
$3.29M Buy
+13,123
New +$3.13M 0.8% 39

Other funds holding AMGN

Stonnington Group's AMGN Position: Q1 2023 in Review

Stonnington Group reduced its Amgen (AMGN) stake by 8.7% in Q1 2023, selling an estimated $541K and leaving 23,153 shares worth $5.82M. The position accounts for 1.52% of the portfolio, ranked #9.

Stonnington Group first reported a position in AMGN in Q1 2021 and has held it in 9 quarters since. The position peaked at $7.12M in Q2 2022. 2,434 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Stonnington Group held 23,153 shares of Amgen worth $5.82M as of Q1 2023.
  • Stonnington Group sold 2,203 Amgen shares in Q1 2023, an estimated $541K.
  • Amgen made up 1.52% of Stonnington Group's portfolio in Q1 2023, its #9 holding.
  • Stonnington Group first reported a position in Amgen in Q1 2021 and has held it in 9 quarters since.
  • Stonnington Group's Amgen position peaked at $7.12M in Q2 2022.
  • 2,434 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.